ClinicalTrials.Veeva

Menu

Rheumatoid Arthritis Patients and Porphyromonas Gingivalis

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Rheumatoid Arthritis

Treatments

Procedure: synovial tissue
Procedure: blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT02905175
2014-A01688-39 (Other Identifier)
1408022

Details and patient eligibility

About

Rheumatoid arthritis (RA) is the most frequent joint inflammatory disease inducing joint destruction strongly correlated with anti-citrullinated protein antibodies citrullinated anti-peptide (ACPA). Precise RA etiology remained unclear with a described association between RA and periodontal disease. The missing link could be a gram-negative anaerobic bacterium called Porphyromonas gingivalis (P. gingivalis), which is heavily involved in periodontal disease and able to induce gingival citrullinated protein via an enzyme called peptidyl arginine deiminase (PAD). DNA of P. gingivalis was detected in synovial tissue and in peripheral blood mononuclear cell. To improve knowledge of P. gingivalis involvement in RA, the investigators will compare its effect on various cell type with comparison with another oral bacteria Provatella intermedia.

Enrollment

11 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >18 ans
  • RA or osteoarthritis with joint surgery planned
  • Informed consent approved and signed

Exclusion criteria

  • Pregnancy

Trial design

11 participants in 2 patient groups

Rheumatoid arthritis
Description:
blood sample specimen and synoviocytes from synovial tissue
Treatment:
Procedure: blood sample
Procedure: synovial tissue
Osteoarthritis
Description:
blood sample specimen and synoviocytes from synovial tissue
Treatment:
Procedure: blood sample
Procedure: synovial tissue

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems